Project 3 Project Abstract The work described in this project aims to expedite the process from drug discovery to clinical application by identifying patients who are likely to respond to a particular drug, or drug combination, before it is administered to them. It describes a plan that takes advantage of new methods to culture human cells, maintaining their innate physiologic properties and making them amenable to screening for drug responses. The project uses cells from cystic fibrosis patients carrying a variety of disease-causing mutations and determines which patients, and which mutations, respond to various drugs. In cases where multiple drugs elicit responses, the ability of the drugs to act additively or even synergistically will be tested. These studies will serve as pre- clinical assessments for later clinical trials. This study focuses on cystic fibrosis, but as small molecule screens identify putative drugs for other disorders, the approach outlined here would be applicable to any disorder in which a screening process could be developed.
The work described in this project aims to expedite the process from drug discovery to clinical application by identifying patients who are likely to respond to a particular drug before it is administered to them. It describes a plan that takes advantage of new methods to culture human cells, maintaining their innate physiologic properties and making them amenable to screening for drug responses. The project uses cells from cystic fibrosis patients carrying a variety of disease-causing mutations and determines which patients, and which mutations, respond to various drugs. In cases where multiple drugs elicit responses, the ability of the drugs to act additively or even synergistically will be tested. These studies will serve as pre-clinical assessments for later clinical trials. This study focuses on cystic fibrosis, but as small molecule screens identify putative drugs for other disorders, the approach outlined here would be applicable to any disorder in which a screening process could be developed.
| Zhou, Hua-Lin; Stomberski, Colin T; Stamler, Jonathan S (2018) Cross Talk Between S-Nitrosylation and Phosphorylation Involving Kinases and Nitrosylases. Circ Res 122:1485-1487 |
| Powell, Cameron J; Ramaswamy, Raghavendran; Kelsen, Anne et al. (2018) Structural and mechanistic insights into the function of the unconventional class XIV myosin MyoA from Toxoplasma gondii. Proc Natl Acad Sci U S A 115:E10548-E10555 |
| Stsiapura, Vitali I; Bederman, Ilya; Stepuro, Ivan I et al. (2018) S-Nitrosoglutathione formation at gastric pH is augmented by ascorbic acid and by the antioxidant vitamin complex, Resiston. Pharm Biol 56:86-93 |
| Rizza, Salvatore; Cardaci, Simone; Montagna, Costanza et al. (2018) S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy. Proc Natl Acad Sci U S A 115:E3388-E3397 |
